Therapeutic Botulinum Toxin – Market Insights – Global
Global therapeutic BTX procedure volumes—and thus product sales and revenues—will be supported by the need for existing patients to return for maintenance procedures, as well as rising demand among new patients driven by expanding indications.
This Medtech 360 Report provides comprehensive data and analysis on the state of the market for therapeutic BTX in the US, Europe, and the Asia Pacific region from 2019 through 2032.
New indication approvals and existing indication expansions will be significant drivers in the therapeutic BTX market.
Which indications contribute the most to growth, and which have the largest market potential?
What regional differences exist regarding indication approvals?
Which competitors have been targeting these indications?
Global therapeutic BTX markets are becoming increasingly consolidated.
What are some key competitive strategies currently being leveraged or can potentially be employed to succeed in the market?
How do the competitive landscapes differ by region, and what considerations must companies make in particular markets?
Markets vary greatly by region in terms of size and growth, with the US market experiencing the fastest expansion globally.
What key drivers are contributing to each regional market’s relative size and growth?
How does pricing vary by region, and what factors most significantly affect pricing within each market?
How does the reimbursement of therapeutic BTX products influence the pricing and adoption of these products across different indications and geographies?
Table of contents
- Therapeutic Botulinum Toxin - Market Insights - Global
- COVID-19 Methodology
- Abstract
- Executive Summary
- Key Report Updates
- Global Therapeutic Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Therapeutic BTX Product Overview, Global, 2022/2023
- Mean Dosages, by Indication and Brand, Global
- BTX Units Used per Procedure, by Indication, Global
- BTX Product Equivalencies, by Brand
- Approved Indications, by Brand, US, 2022/2023
- Approved Indications, by Brand, Europe, 2022/2023
- Approved Indications, by Brand, Asia Pacific, 2022/2023
- Market Forecast Data
- CAGR Disclaimer
- Therapeutic BTX Procedures, by Indication, Global, 2019u20132032
- Therapeutic BTX Procedures, by Region, Global, 2019u20132032
- Therapeutic BTX Market, by Indication, Global (USD), 2019u20132032
- Therapeutic BTX Market, by Region, Global (USD), 2019u20132032
- Therapeutic BTX Market Growth, by Region, Global, 2022u20132032
- Market Shares
- Competitive Insights
- Market Developments
- US Therapeutic Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR Disclaimer
- Therapeutic BTX Procedures, by Indication, US, 2019u20132032
- Spasticity Therapeutic BTX Procedures, by Anatomy, US, 2019u20132032
- Spasticity Therapeutic BTX Procedures, by Age Group, US, 2019u20132032
- Overactive Bladder Therapeutic BTX Procedures, by Cause, US, 2019u20132032
- Therapeutic BTX Market, by Indication, US (USD), 2019u20132032
- Therapeutic BTX Market, US (USD), 2019u20132032
- Market Shares
- Competitive Insights
- European Therapeutic Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR Disclaimer
- Therapeutic BTX Procedures, by Indication, Europe, 2019u20132032
- Therapeutic BTX Procedures, by Country, Europe, 2019u20132032
- Therapeutic BTX Procedures, by Indication, France, 2019u20132032
- Therapeutic BTX Procedures, by Indication, Germany, 2019u20132032
- Therapeutic BTX Procedures, by Indication, Italy, 2019u20132032
- Therapeutic BTX Procedures, by Indication, Spain, 2019u20132032
- Therapeutic BTX Procedures, by Indication, UK, 2019u20132032
- Therapeutic BTX Market, by Indication, Europe (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Country, Europe (USD), 2019u20132032
- Therapeutic BTX Market, by Country, Europe (EUR and GBP), 2019u20132032
- Therapeutic BTX Market Growth, by Country, Europe, 2022u20132032
- Therapeutic BTX Market, by Indication, France (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Indication, Germany (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Indication, Italy (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Indication, Spain (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Indication, UK (USD and EUR), 2019u20132032
- Therapeutic BTX Market, by Indication, UK (GBP), 2019u20132032
- Market Shares
- Competitive Insights
- Asia Pacific Therapeutic Botulinum Toxin Market
- Market Highlights
- Market Definitions
- Market Forecast Data
- CAGR Disclaimer
- Therapeutic BTX Procedures, by Indication, Asia Pacific, 2019u20132032
- Therapeutic BTX Procedures, by Country, Asia Pacific, 2019u20132032
- Therapeutic BTX Procedures, by Indication, Australia, 2019u20132032
- Spasticity Therapeutic BTX Procedures, by Anatomy, Australia, 2019u20132032
- Spasticity Therapeutic BTX Procedures, by Age Group, Australia, 2019u20132032
- Overactive Bladder Therapeutic BTX Procedures, by Cause, Australia, 2019u20132032
- Therapeutic BTX Procedures, by Indication, Japan, 2019u20132032
- Therapeutic BTX Market, by Indication, Asia Pacific (USD), 2019u20132032
- Therapeutic BTX Market, by Country, Asia Pacific (USD), 2019u20132032
- Therapeutic BTX Market, by Indication, Australia (USD), 2019u20132032
- Therapeutic BTX Market, Australia (USD), 2019u20132032
- Therapeutic BTX Market, by Indication, Japan (USD), 2019u20132032
- Therapeutic BTX Market, Japan (USD), 2019u20132032
- Market Shares
- Competitive Insights
- Appendix
Dr. Parth Gandhi is an associate healthcare research and data analyst within the Orthopedics, Dental, and Aesthetics Medtech Insights team at Clarivate, specializing in the aesthetics, therapeutic botulinum toxin, and sports medicine device markets. Parth holds a Doctor of Pharmacy degree from Manipal College of Pharmaceutical Sciences, Manipal Academy of Higher Education, Karnataka.